- Home
- CODX vs BNZI Comparison
CODX vs BNZI Comparison
Compare CODX & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- BNZI
- Stock Information
- Founded
- CODX 2013
- BNZI 2016
- Country
- CODX United States
- BNZI United States
- Employees
- CODX N/A
- BNZI N/A
- Industry
- CODX Medical/Dental Instruments
- BNZI
- Sector
- CODX Health Care
- BNZI
- Exchange
- CODX Nasdaq
- BNZI Nasdaq
- Market Cap
- CODX 9.8M
- BNZI 11.5M
- IPO Year
- CODX 2017
- BNZI N/A
- Fundamental
- Price
- CODX $0.28
- BNZI $3.85
- Analyst Decision
- CODX Buy
- BNZI Strong Buy
- Analyst Count
- CODX 2
- BNZI 1
- Target Price
- CODX $5.50
- BNZI $240.00
- AVG Volume (30 Days)
- CODX 1.1M
- BNZI 245.2K
- Earning Date
- CODX 08-07-2025
- BNZI 08-13-2025
- Dividend Yield
- CODX N/A
- BNZI N/A
- EPS Growth
- CODX N/A
- BNZI N/A
- EPS
- CODX N/A
- BNZI N/A
- Revenue
- CODX $3,497,583.00
- BNZI $6,827,490.00
- Revenue This Year
- CODX N/A
- BNZI $337.60
- Revenue Next Year
- CODX $42.11
- BNZI $91.81
- P/E Ratio
- CODX N/A
- BNZI N/A
- Revenue Growth
- CODX N/A
- BNZI 52.95
- 52 Week Low
- CODX $0.23
- BNZI $3.51
- 52 Week High
- CODX $2.23
- BNZI $112.00
- Technical
- Relative Strength Index (RSI)
- CODX 51.71
- BNZI 27.24
- Support Level
- CODX $0.26
- BNZI $3.51
- Resistance Level
- CODX $0.29
- BNZI $3.96
- Average True Range (ATR)
- CODX 0.02
- BNZI 0.57
- MACD
- CODX 0.00
- BNZI -0.03
- Stochastic Oscillator
- CODX 64.83
- BNZI 10.47
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.